Increased neural sympathetic activation in fibromyalgia syndrome

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 109-117

  Sarzi Puttini, Piercarlo ^a   Atzeni, Fabiola ^a   Diana, Alessandro ^a   Doria, Andrea ^b   Furlan, Raffaello ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Autonomic nervous system; Fibromyalgia syndrome; Hypothalamic pituitary adrenal axis; Sympathetic overactivity

Indexed keywords

ADRENERGIC STIMULATION; ANXIETY DISORDER; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEPRESSION; DISEASE EXACERBATION; EMOTION; FATIGUE; FIBROMYALGIA; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MUSCULOSKELETAL PAIN; PAIN; SLEEP DISORDER; STIMULUS RESPONSE; STRESS; SYMPTOMATOLOGY; WEATHER;

EID: 33745596389     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.009     Document Type: Conference Paper

References (53)

1. CLAUW, D.J. 1995. The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia. Med. Hypotheses 44: 369-378.
2. WOLFE, F., K. Ross, J. ANDERSON & J.J. RUSSELL. 1995. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38: 19-28.
3. WOLFE, F., H. SMYTHE, M. YUNUS, et al. 1990. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 33: 160-172.
4. GOLDENBERG, D.L. 1993. Do infections trigger fibromyalgia? Arthritis Rheum. 36: 1489-1492.
5. BERGLUND, B., E.L. HARJU, E. KOSEK, et al. 2002. Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 96: 177-187.
6. GRANGES, G. & G. LITTLEJOHN. 1993. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum. 36: 642-646.
7. ADLER, G.K. & R. GEENEN. 2005. Hypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgia. Rheum. Dis. Clin. North Am. 31: 187-202.
8. JÄNIG, W. 1992. Pain and sympathetic nervous system: pathophysiological mechanism. In Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System. S.R. Bannister & C.J. Mathias, Eds. Oxford University Press, New York.
9. DESSEIN, P.H., E.A. SHIPTON, A.E. STANWIX, et al. 2000. Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm? Pain 86: 213-215.
10. MARTINEZ-LAVIN, M. 2002. Management of dysautonomia in fibromyalgia. Rheum. Dis. Clin. North Am. 28: 379-387.
11. TSIGOS, C. & G.P. CHROUSOS. 2002. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 53: 865-871.
12. MAGIAKOU, M.A. & G.P. CHROUSOS. 1994. Corticosteroid therapy, nonendocrine disease, and corticosteroid withdrawal. Curr. Ther. Endocrinol. Metab. 5: 120-124.
13. MILLER, W.L. & J.B. TYRRELL. 1995. The adrenal cortex. In Endocrinology and Metabolism. P. Felig, J.D. Baxter & L.A. Frohman, Eds.: 555-711. McGraw-Hill, Inc. New York.
14. LARIVIERE, W.R. & R. MELZACK. 2000. The role of corticotropin- releasing factor in pain and analgesia. Pain 84: 1-12.
15. BRONNEGARD, M., S. WERNER & J.A. GUSTAFSSON. 1986. Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. J. Clin. Invest. 78: 1270-1278.
16. CHROUSOS, G.P, S.D. TERA-WADLEIGH & M. KARL. 1993. Syndromes of glucocorticoid resistance. Ann. Intern. Med. 119: 1113-1124.
17. GRIEP, E.N., J.W. BOERSMA & E.R. DE KLOET. 1993. Altered reactivity of the hypothalamicpituitary-adrenal axis in the primary fibromyalgia syndrome. J. Rheumatol. 20: 469-474.
18. WEIGENT, D.A., L.A. BRADLEY, J.E. BLALOCK, et al. 1998. Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia. Am. J. Med. Sci. 315: 405-412.
19. NEECK, G. 1992. Thyroid function in patients with fibromyalgia syndrome. J. Rheumatol. 19: 1120-1122.
20. BAGGE, E., B.A. BENGTSSON, L. CARLSSON, et al. 1998. Low growth hormone secretion in patients with fibromyalgia - a preliminary report on 10 patients and 10 controls. J. Rheumatol. 25: 145-148.
21. LANDIS, C. A., M.J. LENTZ, J. ROTHERMEL, et al. 2001. Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia. J. Clin. Endocrinol. Metab. 86: 1672-1678.
22. BENNETT, R.M., D.M. COOK, S.R. CLARK, et al. 1997. Hypothalamic- pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J. Rheumatol. 24: 1384-1389.
23. BENNETT, R.M., S.R. CLARK, S.M. CAMPBELL, et al. 1992. Low levels of somatomedin C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum. 35: 1113-1116.
24. WEHRENBERG, W.B., B.A. JANOWSKI, A.W. PIERING, et al. 1990. Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion. Endocrinology 126: 3200-3203.
25. MCCALL-HOSENFEL, J.S., D.L. GOLDENBERG, S. HURWITZ, et al. 2003. Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. J. Rheumatol. 30: 809-814.
26. KORSZUN, A., E.A. YOUNG, N.C. ENGLEBERG, et al. 2000. Follicular phase hypothalamic pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J. Rheumatol. 27: 1526-1530.
27. RUSSELL, I.J., J.E. MICHALEK, G.A. VIPRAIO, et al. 1992. Platelet H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J. Rheumatol. 19: 104-109.
28. BUSKILA, D. & J. PRESS. 2001. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue. Best Pract. Res. Clin. Rheumatol. 15: 747-758.
29. RUSSELL, I.J., M.D. ORR, B. LITTMAN, et al. 1994. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 37: 1593-1601.
30. DEMITRACK, M.A. & L.J. CROFFORD. 1998. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 840: 684-697.
31. SCHOTT, G.D. 1992. Pain and the sympathetic nervous system. In Autonomic Failure, a Textbook of Clinical Disorders of the Autonomic Nervous System. S.R. Bannister & C.J. Mathias, Eds.: 904-916. Oxford University Press. Oxford.
32. BOU-HOLAIGAH, I., H. CALKINS, J.A. FLYNN, et al. 1997. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin. Exp. Rheumatol. 15: 239-246.
33. EVANS, J.A. 1946. Reflex sympathetic dystrophy. Surg. Clin. North Am. 26: 435-448.
34. BARON, R.M., J.D.M.P. LEVINE & H.M.P. FIELDS. 1999. Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain? Muscle Nerve 22: 678-695.
35. NARKIEWICZ, K. & V.K. SOMERS. 1998. Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? Circulation 98: 2105-2107.
36. FURLAN, R., G. JACOB, M. SNELL, et al. 1998. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 98: 2154-2159.
37. MARTINEZ-LAVIN, M. 2004. Fibromyalgia as a sympathetically maintained pain syndrome. Curr. Pain Headache Rep. 8: 385-389.
38. ELAM, M., G. JOHANSSON & B. WALLIN. 1992. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 48: 371-375.
39. BACKMAN, E., A. BENGTSSON, M. BENGTSSON, et al. 1998. Skeletal muscle functions in primary fibromyalgia: effect of regional sympathetic blockade with guanethidine. Acta Neurol. Scand. 77: 187-191.
40. COHEN, H., L. NEUMANN, M. SHORE, et al. 2000. Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Semin. Arthritis Rheum. 29: 217-227.
41. MARTINEZ-LAVIN, M., A.G. HERMOSILLO, M. ROSAS, et al. 1998. Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum. 41: 1966-1971.
42. MARTINEZ-LAVIN, M., A.G. HERMOSILLO, C. MENDOZA, et al. 1997. Orthostatic sympathetic derangement in subjects with fibromyalgia. J. Rheumatol. 24: 714-718.
43. RAJ, S.R., D. BROUILLARD, C.S. SIMPSON, et al. 2000. Dysautonomia among patients with fibromyalgia: a noninvasive assessment. J. Rheumatol. 27: 2660-2665.
44. FURLAN, R., S. COLOMBO, F. PEREGO, et al. 2005. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J. Rheumatol. 32: 1787-1793.
45. DAVIS S.N., P. GALASSETTI, D.H. WASSERMAN, et al. 2000. Effects of gender on neuroendocrine and metabolic counter regulatory responses to exercise in normal man. J. Clin. Endocrinol. Metab. 85: 224-230.
46. KIRSCHBAUM, C., B.M. KUDIELKA, J. GAAB, et al. 1999. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 61: 154-162.
47. VAN, H.B. & U.T. EGLE. 2004. Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together. Psychother. Psychosom. 73: 267-275.
48. AKO, M., T. KAWARA, S. UCHIDA, et al. 2003. Correlation between electroencephalography and heart rate variability during sleep. Psychiatry Clin. Neurosci. 57: 59-65.
49. TRINDER, J., J. KLEIMAN, M. CARRINGTON, et al. 2001. Autonomic activity during human sleep as a function of time and sleep stage. J. Sleep Res. 10: 253-264.
50. ALBRIGHT, G.L., J.L. ANDREASSI & A.L. BROCKWELL. 1991. Effects of stress management on blood pressure and other cardiovascular variables. Int. J. Psychophysiol. 11: 213-217.
51. GOLDSMITH, R.L., D.M. BLOOMFIELD & E.T. ROSENWINKEL. 2000. Exercise and autonomic function. Coron. Artery Dis. 11: 129-135.
52. CLARK, S., E. TINDALL & R.M. BENNETT. 1985. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J. Rheumatol. 12: 980-983.
53. BENNETT, R.M., S.C. CLARK & J. WALCZYK. 1998. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am. J. Med. 104: 227-231.